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Abstract
Background and aims—Most prior studies investigating the association of lower extremity 
peripheral artery disease (PAD) with physical function were small or analyzed selected 
populations (e.g., patients at vascular clinics or persons with reduced function), leaving particular 
uncertainty regarding the association in the general community.
Methods—Among 5,262 ARIC participants (age 71-90 years during 2011-2013), we assessed 
the cross-sectional association of ankle-brachial index (ABI) with the Short Physical Performance 
Battery (SPPB) score (0-12), its individual components (chair stands, standing balance, and gait 
speed) (0-4 points each), and grip strength after accounting for potential confounders, including a 
history of coronary disease, stroke, or heart failure.
Results—There were 411 participants (7.8%) with low ABI ≤0.90 and 469 (8.9%) participants 
with borderline low ABI 0.91-1.00. Both ABI ≤0.90 and 0.91-1.00 were independently associated 
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with poor physical function (SPPB score ≤6) compared to ABI 1.11-1.20 (adjusted odds ratio 2.10 
[95% CI 1.55-2.84] and 1.86 [1.38-2.51], respectively). The patterns were largely consistent across 
subgroups by clinical conditions (e.g., leg pain or other cardiovascular diseases), in every SPPB 
component, and for grip strength. ABI >1.3 (472 participants [9.0%]), indicative of non-
compressible pedal arteries, was related to lower physical function as well but did not necessarily 
reach significance.
Conclusions—In community-dwelling older adults, low and borderline low ABI suggestive of 
PAD were independently associated with poorer systemic physical function compared to those 
with normal ABI. Clinical attention to PAD as a potential contributor to poor physical function is 
warranted in community-dwelling older adults.
Keywords
Peripheral artery disease; physical function; aging
Introduction
Lower extremity peripheral artery disease (PAD), commonly defined as ankle-brachial index 
(ABI) <0.9, affects 8-10 million individuals in the US1-3 and more than 200 million 
individuals around the globe,2 with particularly high prevalence in older adults.4 Of note, its 
prevalence increased by 24% globally in the last decade.2 Persons with PAD are well-known 
to have increased mortality risk, mainly due to cardiovascular disease.5 Indeed, patients with 
PAD have 3-6 fold higher risk of 10-year mortality compared to those without.5 Leg 
amputation is another critical consequence of PAD, and more than 150,000 legs are 
amputated annually due to PAD in the US.1
Reduced physical function has been investigated as a potential consequence of PAD. 
However, several previous studies have reported conflicting results regarding PAD and 
objectively assessed physical function.6-17 Many of these studies were small (n <1,000) and 
had limited statistical power.6-8, 12-17 More importantly, most of these studies investigated 
selected populations (i.e., patients from vascular labs and clinics,6-8, 12, 15-17 persons with 
disability13, 14 or reduced physical function plus sedentary lifestyle9, or only 
women10, 13, 14), leaving uncertainty regarding the impact of PAD on physical function in 
the community. Therefore, the aim of this study is to assess the cross-sectional association of 
a representative indicator of PAD, ABI, with objectively measured physical function, using 
data from a biracial community-based cohort, the Atherosclerosis Risk in Communities 
(ARIC) Study.
Materials and methods
Study participants
The ARIC Study consisted of 15,792 participants who were aged 45–64 years at visit 1 
during the period 1987–1989 and were recruited from four communities in the US: 
Washington County, Maryland; suburban Minneapolis, Minnesota; Jackson, Mississippi; and 
Forsyth County, North Carolina.18 Subsequently, three follow-up visits were performed 
triennially (visits 2, 3, and 4 during 1990-1992, 1993-1995 and 1996-1998, respectively). 
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Visit 5 was recently conducted during 2011–2013 and included the first assessments of 
physical function and ABI in both legs; visit 5 serves as baseline for the present study. 
Among 6,538 participants who attended visit 5, we excluded participants who reported race 
other than white or black (n=18), due to small numbers, or had missing values of ABI 
(n=868), physical function (n=123), or covariates of interest (n=267), leaving a final study 
population of 5,262 participants. The study was approved by the Institutional Review Boards 
of all participating institutions, and all participants gave informed consent.
Ankle-brachial index
Using OMRON VP-1000 plus (Kyoto, Japan), an oscillometric device, blood pressure was 
automatically measured twice, five minutes apart in both ankles and brachia by certified 
technicians.19 Using the higher value of the right or left brachial systolic blood pressure as 
the denominator, the ABI, the ratio of ankle systolic blood pressure to brachial systolic 
blood pressure,20 was calculated for right and left legs. The mean ABI of two measurements 
was recorded for each leg. In general, the lower value of right and left ABI was used for our 
analysis. Only when the higher ABI exceeded 1.3 and the lower ABI was normal (1.0-1.3), 
did we use the higher ABI value >1.3 for the analysis, to avoid missing potentially 
pathophysiological information from exceptionally high ABI indicating arterial non-
compressibility.21-24
Objective measures of physical function
Short Physical Performance Battery (SPPB)—Physical function was assessed using 
the Short Physical Performance Battery (SPPB) as a measure of lower extremity 
performance25, 26 and grip strength as a measure of upper body strength.27 Briefly, the SPPB 
consists of three components of physical performance, chair stands, standing balance, and 
gait speed. A point from 0 (poorest) to 4 (best) was assigned for each of these three 
components, based on population-based norms. The sum of the scores provided a composite 
score ranging from 0 to 12 for each participant, and SPPB score ≤6 was considered as poor 
physical function as previously reported.26 We analyzed both SPPB score as a composite 
measure of physical function and each component of chair stands, standing balance, and gait 
speed, separately.
Chair stands—Participants were timed standing from and sitting on a chair five times 
within 60 seconds, with their arms crossed on their chest. The ability of and time for 
accomplishing the task determined the score (0 points if unable to accomplish, 1 point if it 
took 16.7 to 60 seconds, 2 points if 13.7 to <16.7 seconds, 3 points if 11.2 to <13.7 seconds, 
and 4 points if <11.2 seconds). We also investigated time to accomplish five chair stands as a 
continuous variable. For those who could not complete five stands within 60 seconds, we 
conservatively allocated 60 seconds.
Standing balance—The ability to maintain standing posture for 10 seconds with three 
different foot positions, side-by-side (easiest), semi-tandem (intermediate), and tandem 
(hardest), beginning with the semi-tandem position.28 Participants who could not complete 
semi-tandem were tested for side-by-side. Those who completed semi-tandem were assumed 
to be able to complete side-by-side and subsequently evaluated in the tandem stand. Two 
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trials were allowed for tandem standing balance if needed. Upon accomplishment, one point 
was provided for each of side-by-side stand and semi-tandem stand; one point was given if 
the tandem stand was held 3 to <10 seconds and two points if the tandem stand was held for 
10 seconds (minimum of 0 to maximum of 4 points in total for this test of standing balance). 
We also analyzed time of holding stand with maximum of 10 seconds for each feet position 
as continuous variables.
Gait speed—Participants were timed walking 4 meters at their usual speed, and the faster 
of the two trials was recorded for analysis. Participants were encouraged not to use walking 
aids but were allowed per participants’ discretion. The point was determined by ability and 
time as follows: 0 point if unable to accomplish, 1 point if it took ≥8.70 seconds, 2 points if 
6.21 to <8.70 seconds, 3 points if 4.82 to <6.21 seconds, and 4 points if <4.82 seconds. 
Dividing 4 meters by the time required to walk this distance, we calculated walking velocity 
(m/sec) and used it as a continuous variable in the analysis as well.
Grip strength—Grip strength in kilograms of force was assessed using Jamar Hydraulic 
Hand Dynamometer in participant's preferred hand (usually the dominant). The better of two 
trials was used for the analysis.
Other variables—ARIC study participants provided information on demographic and 
behavioral variables and medical history to a trained interviewer. Physical assessment and 
blood sample collection were performed according to standardized procedures.29 Age, 
gender, race, education level, smoking, alcohol intake, leg pain, and physical activity were 
based on self-report. Completed years of education were categorized into <12, 12 to 16, or 
>16 years. Smoking status and alcohol intake were dichotomized as current vs. former/
never. The presence of leg pain due to artery blockage was based on the questionnaire during 
annual telephone follow-ups prior to visit 5. Physical activity was categorized into five 
categories regarding whether they do any exercise during leisure time (never, seldom, 
sometimes, often, and very often). For systolic blood pressure as a covariate, we used the 
average of the last two of three readings, which were measured by certified technicians with 
participants in the sitting position after 5-minute rest using a validated automatic 
sphygmomanometer (the OMRON HEM-907 XL). Participants were asked to bring all 
medications including antihypertensive, antidyslipidemic, and antidiabetic drugs, which 
were coded by trained personnel. Diabetes mellitus was defined as a fasting glucose ≥7.0 
mmol/L, non-fasting glucose ≥11.1 mmol/L, self-reported physician diagnosis of diabetes, 
or use of glucose lowering medications. Total cholesterol and high-density lipoprotein 
cholesterol were determined using enzymatic methods meeting the National Cholesterol 
Education Program's accuracy performance criteria. Body mass index was defined as weight 
(kg) divided by the square of height (m2). Prevalent coronary heart disease and stroke were 
defined as self-reported history at visit 1 or adjudicated clinical events between visit 1 and 
visit 5. Hospitalization for heart failure, physician diagnosis of heart failure, and self-
reported treatment for heart failure between visits 1 and 5 were considered prevalent heart 
failure.
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Statistical analysis
According to previous literature9, 30 and the distribution in the ARIC Study, ABI was 
divided into the following six categories: ≤0.90 (low ABI31), 0.91-1.00 (borderline low20), 
1.01-1.10, 1.11-1.20, 1.21-1.30, and >1.30 (high ABI31). The category of 1.11-1.20 was 
used as reference since this category was most prevalent in our study and was used as a 
reference in the ABI Collaboration.32 First, baseline characteristics were compared across 
these ABI categories based on ANOVA and chi-square tests, as appropriate.
Subsequently, multivariable linear regression models were examined with the SPPB score or 
its components as dependent variables. To specifically capture the contribution of ABI to 
poor physical function, we also constructed multivariable logistic regression models with 
SPPB score ≤6 defined as poor performance26 and ≤2 points of each of three components 
(threshold of ≤6 divided by three components) of chair stands, standing balance, and gait 
speed as dependent variables. We also modeled time required for chair stands, time held 
while standing, and walking velocity as well as grip strength as continuous dependent 
variables using linear regression models.
We evaluated two sets of covariates. Our primary model included a list of potential 
confounders: age, gender, race, education, smoking, alcohol intake, body mass index, 
diabetes, systolic blood pressure, antihypertensive drugs, total and high-density lipoprotein 
cholesterols, lipid-lowering drugs, and history of coronary heart disease, stroke, and heart 
failure. Our secondary model additionally included potential mediators, leg pain and 
physical activity.
Finally, we repeated our analyses in several prespecified subgroups by age, gender, race, 
diabetes, smoking status, history of cardiovascular disease (a composite of coronary disease, 
stroke, and heart failure), and presence/absence of leg pain related to PAD. Interaction by 
these factors was assessed with likelihood ratio test by comparing two models with and 
without product terms of ABI categories and each of those factors. All analyses were 
performed with Stata version 14.0, and a p-value <0.05 was considered statistically 
significant.
Results
The mean age of 5,262 participants was 75.3 (SD 5.0) years. There were 411 participants 
(7.8%) with a low ABI ≤0.90 and 469 (8.9%) with a borderline low ABI of 0.91-1.00. High 
ABI >1.3 was observed in 472 subjects (9.0%). As compared to participants with ABI of 
1.11-1.20 in the reference range, those with low and borderline low ABI were likely to be 
older and blacks and to have worse cardiovascular risk factor profiles, such as higher 
prevalence of current smoking, diabetes, antihypertensive use, and history of cardiovascular 
disease (Table 1). Participants with low ABI were more likely to be men, whereas those with 
borderline low ABI were more likely to be women. Those with high ABI also demonstrated 
a worse profile for diabetes, antihypertensive use, and prevalent coronary disease and stroke, 
compared to those with ABI 1.11-1.20. There was generally a dose-response relationship of 
lower ABI to higher prevalence of leg pain and physical inactivity (“never” and “seldom” for 
leisure time exercise).
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Even after accounting for the differences in these characteristics, significantly lower SPPB 
score was observed in both low ABI ≤0.9 and borderline low ABI 0.91-1.00 compared to the 
referent ABI (8.77 [95% CI 8.56-8.98], p<0.001, and 9.19 [9.00-9.38], p=0.002, 
respectively, vs. 9.53 [9.44-9.63]) (Fig. 1A). High ABI >1.3 showed significantly lower 
SPPB score compared to the reference ABI as well. Similarly, low ABI and borderline low 
ABI categories were associated with poor overall physical function (SPPB score ≤6) (odds 
ratio 2.10 [95% CI 1.55-2.84], 1.86 [1.38-2.51], and 1.35 [0.93-1.94], respectively, with ABI 
1.11-1.20 as the reference) (Fig. 1B). The associations with high ABI in this logistic 
regression model did not reach significance (p-value 0.111). Further adjustment for leg pain 
and physical activity did not materially change the results (Supplemental Fig. 1). Although 
the number of participants was limited, the dose-response relationship was observed after 
subdividing ABI ≤0.9 into three categories of ≤0.7 (n=133), 0.71-0.8 (n=97), and 0.81-0.9 
(n=181) (Supplemental Fig. 2).
Low ABI ≤0.90 and borderline low ABI 0.91-1.00 were largely consistently associated with 
poorer scores of each SPPB component compared to ABI 1.11-1.20, regardless of the 
additional adjustment for leg pain and physical activity (Fig. 2 and Supplemental Fig. 3). 
The poorer performance was more evident when time required for chair stand, time able to 
hold standing, and walking velocity were analyzed as continuous variables (Table 2). For 
example, compared to those with ABI 1.11-1.20, those with low ABI ≤0.9 took 2.82 (95% 
CI 1.50-4.13) seconds more for chair stands on average (19.26 [18.07-20.44] seconds vs. 
16.44 [15.90-16.98] seconds), held the semi-tandem stand 0.40 (0.16-0.64) seconds less 
comparing the medians (9.01 [interquartile interval, 8.80-9.23] seconds vs. 9.42 [9.32-9.51] 
seconds), and walked 0.07 (0.05-0.09) m/s slower on average (0.89 [0.87-0.91] meter/second 
vs. 0.96 [0.95-0.97] meter/second) (all p-values <0.05). Both low ABI and borderline low 
ABI groups demonstrated lower grip strength compared to ABI 1.11-1.20. Although the 
high ABI group demonstrated worse performance in each of the SPPB components and grip 
strength compared to the reference ABI group, none of them were statistically different. 
Largely consistent results were seen when we stratified by gender (Supplemental Tables 1 
and 2) or further adjusted for leg pain and physical activity (Supplemental Table 3).
Given the results above and to obtain reliable estimates in each of subgroups, we 
dichotomized ABI as ≤1.00 vs. 1.01-1.30 for subgroup analysis (Fig. 3). Participants with 
ABI ≤1.00 compared to ABI 1.01-1.30 showed higher odds of poor physical function in all 
demographic and clinical subgroups tested. The association did not reach significance only 
in the subgroup of participants with leg pain, but the interaction was not statistically 
significant (p for interaction 0.342).
Discussion
To our knowledge, this is the largest study exploring the associations between ABI and 
objectively measured physical function. We observed that lower ABI was robustly associated 
with poor physical function in community-dwelling older adults. Of importance, the 
association was independent of a history of other cardiovascular diseases, coronary heart 
disease, stroke, and heart failure. Lower ABI was consistently associated with three different 
components of SPPB. Of note, those with high ABI, indicating non-compressibility of the 
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artery with or without PAD, had lower physical function as well, although the results did not 
necessarily reach statistical significance.
Our results are in line with and build upon previous studies showing positive associations of 
lower ABI or clinical diagnosis of PAD with objective measurements of impaired physical 
function.6-9, 11-15, 17 Importantly, we, for the first time, confirmed this association in a 
community-based sample of older men and women unselected for PAD status or reduced 
physical function. The significant results for each of the individual SPPB components in the 
present study would be of value, since there was considerable heterogeneity among those 
previous positive studies regarding which individual SPPB components related to PAD and 
each component of the SPPB reflects different physical functions. Specifically, chair stands 
reflect leg strength, balance, and endurance,8 whereas walking involves multiple organ 
systems including muscles, nerves, vision, joints, the heart and lungs. Moreover, this is one 
of few studies reporting lower physical function among those with ABI of 0.91-1.00,9, 33 a 
group currently considered borderline but not as PAD.20 As most of the previous studies 
excluded persons with high ABI,6-8, 10-17 our observations between high ABI and lower 
physical function are of interest.
There are a few plausible mechanisms linking PAD to the reduction of physical function. In 
terms of leg-specific mechanisms, it has been suggested that low blood perfusion of leg 
muscle during physical activity contributes to functional impairment related to PAD.34 In 
severe PAD cases, skeletal muscle atrophy in the legs through ongoing ischemia has been 
reported,35 which can further impact leg-specific physical function. In this connection, we 
confirmed the association of lower ankle blood pressure with reduced physical function 
(Supplemental Fig. 4). However, the independent associations of lower ABI with lower grip 
strength suggest the involvement of systemic pathophysiology. Low ABI is an indicator of 
systemic atherosclerosis and thus, those with low ABI often have other manifestations of 
cardiovascular disease such as stroke and heart failure,36 which may lead to poor systemic 
physical function. However, of note, the association of ABI with physical function was 
independent of other cardiovascular subtypes. Thus, further investigations are needed to 
understand potential pathophysiological mechanisms linking PAD to reduced systemic 
physical function and muscle strength.
High ABI is usually considered indicative of non-compressible pedal arteries, but some 
investigators consider as an indicator of PAD since the proportion of PAD is high in this 
group.37 Thus, the association of high ABI, similar to low ABI, with lower physical function 
performance in our study may not be unexpected. From another perspective, high ABI is 
also considered as a marker of arterial stiffness.38 Importantly, several potential mechanisms 
have been suggested regarding the link between arterial stiffness and impaired physical 
function. Increased arterial stiffness is known to associate with microvascular and 
endothelial abnormalities, which may potentially influence capillary perfusion in the 
exercising extremity and thus reduce the functional capacity of the lower extremities.39 
Also, as reflected on the terminology of ventricular-vascular coupling, structural and 
functional alterations of the arterial system are known to adversely impact left ventricular 
function and structure, which could limit functional capacity.39, 40
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These results suggest several public health and clinical implications. The association of low 
ABI with poor physical function independently of history of other cardiovascular diseases 
suggests a unique value of knowing PAD status. Screening of PAD using ABI is 
controversial since data are not conclusive regarding whether ABI provides information 
beyond the risk of other cardiovascular diseases.31, 41 Thus, it would be of interest to include 
the impact on physical function in this discussion. Indeed, identification of PAD as a cause 
of impaired lower-extremity physical function may have therapeutic implications since 
several studies have demonstrated that lifestyle (e.g., smoking cessation42 or exercise43) or 
medical (e.g., cilostazol44 or revascularization45, 46) interventions may improve physical 
function among patients with PAD and leg symptoms. This is particularly relevant to older 
adults since lower extremity performance is an important predictor to sustain their 
independent living.47 Furthermore, unhindered functional mobility also allows an older adult 
to take part in a range of productive and social activities. In this regard, the difference in 
walking speed between low ABI ≤0.90 vs. 1.11-1.20 in our study exceeded the thresholds of 
meaningfully different walking speed of 0.04-0.06 meter/second.9 Whether those 
interventions are effective among those without PAD-related leg symptoms are yet to be 
investigated.
Several limitations of this study should be acknowledged. The cross-sectional design does 
not allow us to infer temporality between ABI and physical function. ABI was measured 
using an oscillometric device due to feasibility in a large community cohort study, although 
clinical guidelines of PAD recommend using a Doppler probe for measuring ABI.20 
However, the main weakness of oscillometric device is inaccuracy of ABI in severe PAD 
cases.20 Oscillometry-derived ABI has been validated against Doppler-determined ABI 
among healthy individuals and mild PAD cases,20 which seems relevant to a community-
based cohort study like ours. Finally, although we controlled for potential confounders, as 
true for any observational studies, we cannot eliminate the possibility of residual 
confounding.
In conclusion, lower ABI was robustly and consistently associated with lower physical 
function in community-dwelling older adults. Since physical function is a key element for 
independent living in older adults and several therapeutic options for PAD exist, clinical 
attention could be warranted to PAD as a potential contributor to poor lower-extremity 
physical function among older adults.
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Highlights
• In community-dwelling older adults, lower ankle-brachial index (ABI) was 
robustly associated with objective measures of poor physical function.
• Lower ABI was consistently associated with three different components of 
lower-extremity function, squatting, walking speed, and standing balance.
• The association was independent of a history of other cardiovascular diseases, 
namely, coronary heart disease, stroke, and heart failure.
• Those with high ABI, indicating non-compressibility of the artery with or 
without PAD, tended to have lower physical function as well.
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Fig. 1. Association of ABI with total score of the Short Physical Performance Summary (SPPB)
Adjusted SPPB score (A) and adjusted odds ratio of low SPPB score (≤ 6) (B) according to 
ABI categories. The results were adjusted for age, race, sex, education, smoking, alcohol, 
body mass index, antihypertensive drugs, systolic blood pressure, lipid lowering drugs, total 
and HDL cholesterols, diabetes, and history of coronary disease, heart failure, and stroke. * 
Indicates statistical significance with ABI 1.11-1.20 as the reference.
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Fig. 2. Association of ABI with each component of the Short Physical Performance Summary 
(SPPB)
Adjusted score of each component in the SPPB ((A) [chair stand score], (C) [standing 
balance score], and (E) [gait speed score]) and adjusted odds ratio of having low score (≤2) 
of each component ((B) [chair stand score], (D) [standing balance score], and (F) [gait speed 
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score]) according to ABI categories. *Indicates statistical significance with ABI 1.11-1.20 as 
the reference.
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Fig. 3. Adjusted odds ratio of low SPPB score (≤6) according to lower ABI ≤1.00 vs. 1.01-1.30 by 
demographic and clinical subgroups
The results were adjusted for age, race, sex, education, smoking, alcohol, body mass index, 
antihypertensive drugs, systolic blood pressure, lipid lowering drugs, total and HDL 
cholesterols, diabetes, and history of coronary disease, heart failure, and stroke, as 
appropriate.
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